Stent treatment study for blocked heart arteries
Part of Heart & circulation clinical trials.
This study tests a coronary stent approach for people with significantly blocked heart arteries. It may help by improving blood flow, and it compares treatment in a structured way while monitoring safety and outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 19 years old
- You can understand the study and sign consent on your own
- You have heart artery disease that is either stable or happening now as a recent heart problem
- Your scan shows at least one blockage that is more than 50% narrowed and can be treated with a stent
- You are not pregnant
- You are able to take key blood-thinning medicines (aspirin and others used around stent placement) and heparin, and you are not allergic/intolerant to them or to drug-eluting stent medicines like sirolimus or everolimus
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of stent made from magnesium that slowly dissolves over time. It is for people who have a long blockage in a heart artery that has not been treated before and may be a good option for those who are stable and have not had a recent heart attack.
This trial tests a new type of stent (a small mesh tube) that slowly releases a medicine called sirolimus to keep your heart artery open after angioplasty. It is designed for people with narrowing in their heart arteries who need a stent.
This trial tests a new drug-coated stent (GENOSS® DES) for people with blockages in multiple heart arteries. It aims to see how safe and effective the stent is for these patients.
This trial tests whether a drug-coated heart stent (sirolimus with ascorbic acid, a form of vitamin C) works as well as another type (everolimus) for patients with blocked coronary arteries. Both drugs help prevent the stent from becoming blocked again.
This trial compares two types of drug-coated stents (one with sirolimus, one with everolimus) in people who have had a heart attack or unstable angina and need a stent. It aims to see which stent works better for new blockages in the heart arteries.
This study looks at how to treat blocked heart arteries that have narrowed again after a prior drug-eluting stent. It compares using another drug-eluting stent versus a drug-coated balloon, chosen based on an imaging scan inside the artery (OCT), to reduce repeat narrowing.
Hear when a new Ischemic Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.